How Medicare Part D Benefit Phases Affect Adherence with Evidence-Based Medications Following Acute Myocardial Infarction
Article first published online: 6 JUN 2013
© Health Research and Educational Trust
Health Services Research
Volume 48, Issue 6pt1, pages 1960–1977, December 2013
How to Cite
Stuart, B., Davidoff, A., Erten, M., Gottlieb, S. S., Dai, M., Shaffer, T., Zuckerman, I. H., Simoni-Wastila, L., Bryant-Comstock, L. and Shenolikar, R. (2013), How Medicare Part D Benefit Phases Affect Adherence with Evidence-Based Medications Following Acute Myocardial Infarction. Health Services Research, 48: 1960–1977. doi: 10.1111/1475-6773.12073
- Issue published online: 26 NOV 2013
- Article first published online: 6 JUN 2013
|hesr12073-sup-0001-AuthorMatrix.pdf||application/PDF||1097K||Appendix SA1: Author Matrix.|
Table S1: Propensity Score Matched Sample Characteristics (N = 3,050).
Table S2: Estimates of Post-AMI Drug Adherence by LIS Status and Benefit Phase for Matched Sample.
Table S3: Estimates of Post-AMI Drug Use and PDC ≥0.80 by LIS Status and Benefit Phase.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.